Click on the following links to read the articles:

Weigao 3Q Results Below Expectations; Credit Suisse And Nomura Cut Weigao’s Target Prices (11-16-2011)

Goldman Sachs Cuts Target Prices for China Healthcare Shares (7-15-2011)

Credit Suisse Downgrades Shandong Weigao To Neutral, Target Price HK$9.50 (5-12-2011)

Goldman Sachs Bullish on China Healthcare Sector; Revised Sector Players’ Targets (11-25-2010)